Yunlong Yang Selected Research

periviscerokinin

5/2015

Molecular and pharmacological characterization of the Chelicerata pyrokinin receptor from the southern cattle tick, Rhipicephalus (Boophilus) microplus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yunlong Yang Research Topics

Disease

28	Neoplasms (Cancer) 11/2022 - 12/2011
13	Neoplasm Metastasis (Metastasis) 11/2022 - 01/2013
5	Vascular Remodeling 01/2020 - 12/2011
4	Inflammation (Inflammations) 01/2022 - 12/2020
3	Infections 01/2022 - 01/2020
3	Melanoma (Melanoma, Malignant) 11/2021 - 06/2015
3	Wounds and Injuries (Trauma) 01/2019 - 04/2016
2	Glioblastoma (Glioblastoma Multiforme) 10/2022 - 03/2019
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2020
2	Osteoarthritis 11/2021 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 11/2017
2	Hypoxia (Hypoxemia) 11/2017 - 04/2013
2	Lyme Disease (Disease, Lyme) 02/2016 - 05/2015
1	Nasopharyngeal Carcinoma 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Triple Negative Breast Neoplasms 01/2022
1	African Swine Fever 11/2021
1	Osteoporosis 01/2021
1	Stroke (Strokes) 01/2020
1	Fibrosarcoma 01/2020
1	Ischemic Stroke 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019
1	Pressure Ulcer (Bedsore) 01/2019
1	Fever (Fevers) 01/2019
1	Atherosclerosis 01/2019
1	Overactive Urinary Bladder (Overactive Bladder) 01/2019
1	Atherosclerotic Plaque (Atheroma) 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2018
1	Obesity 12/2017
1	Tissue Adhesions 10/2017

Drug/Important Bio-Agent (IBA)

10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2022 - 01/2013
8	Pharmaceutical PreparationsIBA 10/2022 - 04/2013
6	Becaplermin (PDGF-BB)FDA Link 01/2018 - 12/2011
5	Proteins (Proteins, Gene)FDA Link 10/2022 - 12/2011
4	Interleukin-33IBA 01/2022 - 01/2016
4	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2022 - 08/2017
4	HydrogelsIBA 01/2021 - 02/2016
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2017 - 01/2013
2	Messenger RNA (mRNA)IBA 01/2022 - 12/2011
2	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 01/2020
2	Biological ProductsIBA 01/2021 - 06/2015
2	Oxygen (Dioxygen)IBA 01/2020 - 12/2011
2	Bevacizumab (Avastin)FDA Link 11/2017 - 07/2013
2	Erythropoietin FDA Link 11/2017 - 12/2011
2	Biomarkers (Surrogate Marker)IBA 04/2015 - 01/2013
2	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 04/2015 - 01/2013
2	Platelet-Derived Growth FactorIBA 01/2013 - 12/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022
1	SaponinsIBA 10/2022
1	Mannose (D-Mannose)IBA 01/2022
1	Liposomes (Liposome)IBA 01/2022
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2022
1	CXC ChemokinesIBA 01/2022
1	Collagen Type III (Type III Collagen)IBA 01/2022
1	HexosesIBA 01/2022
1	Clodronic Acid (Clodronate)IBA 01/2022
1	Interleukin-8B ReceptorsIBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	LigandsIBA 01/2022
1	CytokinesIBA 01/2022
1	VaccinesIBA 11/2021
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 11/2021
1	Histocompatibility Antigens Class IIBA 11/2021
1	glucose-regulated proteinsIBA 11/2021
1	polyethylene glycol- distearoylphosphatidylethanolamineIBA 11/2021
1	Surface Antigens (Surface Antigen)IBA 11/2021
1	Blood Glucose (Blood Sugar)IBA 11/2021
1	FructoseIBA 11/2021
1	AntigensIBA 11/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	ZirconiumIBA 12/2020
1	EsterasesIBA 12/2020
1	Photosensitizing Agents (Photosensitizers)IBA 12/2020
1	ProdrugsIBA 12/2020
1	Eicosanoid Receptors (Eicosanoid Receptor)IBA 01/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2019
1	mirabegronIBA 01/2019
1	Mitochondrial Uncoupling ProteinsIBA 01/2019
1	ApolipoproteinsIBA 01/2019
1	Apolipoproteins E (ApoE)IBA 01/2019
1	Galactose (Galactopyranose)FDA LinkGeneric 01/2019
1	LDL CholesterolIBA 01/2019
1	LDL Receptors (LDL Receptor)IBA 01/2019
1	Peptide Receptors (Peptide Receptor)IBA 01/2019
1	laminin AIBA 10/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2018
1	Nonesterified Fatty Acids (NEFA)IBA 07/2018
1	Immunoglobulin G (IgG)IBA 01/2018

Therapy/Procedure

15	Therapeutics 01/2022 - 01/2013
4	Drug Therapy (Chemotherapy) 10/2022 - 01/2017
2	Immunotherapy 01/2022 - 01/2018
1	Radiotherapy 01/2022
1	Injections 01/2021
1	Induced Hyperthermia (Thermotherapy) 12/2020
1	Photothermal Therapy 12/2020
1	Intravenous Injections 01/2020
1	Oral Administration 01/2019